The Bermuda Form is the high-excess casualty contract of the global insurance market. Bermuda Form 004 (1986 base form, updated periodically) and Bermuda Form 006 (more recent and more responsive to long-tail mass-tort claims) provide occurrence-reported coverage with London-arbitration jurisdiction and New York substantive law on the policy. A long-tail mass-tort claim - PFAS, opioid, talc, glyphosate, asbestos-derivative - against an insured with a Bermuda Form high-excess layer turns on five questions: what constitutes an "occurrence" under the form's batch, non-batch, and aggregation language; when notice was given (the reporting trigger that defines which policy period responds); whether the "expected or intended" exclusion applies; what aggregation principles govern across multiple claimants and multiple manufacturing years; and what arbitration posture the carrier takes under London arbitration with NY substantive law. This lesson walks the Bermuda Form occurrence-reported trigger analysis on a PFAS mass-tort scenario at a $25M xs $25M layer, drafts the coverage position memo for the Bermuda-domiciled excess carrier, produces the cedent's counter-position, and surveys the Munich Re Bermuda, Tokio Marine HCC, Markel Bermuda, and AXA XL Bermuda market posture on AI-driven aggregation analysis. The headline rule: Bermuda Form coverage is decided in London arbitration under New York substantive law; the coverage position memo must contemplate that forum and that substantive law from the first draft onward, because every clause that surfaces at the underwriting box will be read against NY case law by a London arbitrator three years downstream.

The Bermuda Form Architecture

Bermuda Form 004: the original 1986 form developed for Bermuda-domiciled excess casualty carriers (ACE, XL, ACE Tempest Re, and the wave of Bermuda specialty markets that opened in the 1985-1986 liability crisis). Provides occurrence-reported coverage on a per-claim basis; the original draft addressed the asbestos and environmental claims that had broken the US excess-casualty market. Bermuda Form 006: the refined iteration introduced in the early 2000s and updated through 2024-2025, with sharper trigger and aggregation language, more responsive treatment of long-tail mass-tort claims, and explicit batch-clause architecture. Both forms share specific features: London-arbitration jurisdiction; New York substantive law applies to policy interpretation; high attaching layer typically ($25M xs $25M at the lower end; high-excess $50M xs $200M or higher on the largest placements); maintenance deductible per occurrence; aggregate limit per policy period; annual policy period with renewal as the cedent's option.

Why London and New York. London arbitration provides specialized commercial arbitrators familiar with high-excess casualty disputes; arbitration confidentiality is preferred by both the insurer and the policyholder because the dispute frequently involves the insured's underlying confidential business data; arbitration awards are enforceable internationally under the New York Convention (technically the 1958 Convention on the Recognition and Enforcement of Foreign Arbitral Awards). New York substantive law is well-developed in insurance jurisprudence, familiar to Bermuda-domiciled carriers and US-domiciled insureds, and predictable in interpretation. Combined, the London-and-NY framework produces an efficient, confidential, sophisticated forum with predictable law that the policyholder's NYSE-listed parent and the Bermuda excess carrier both accept.

The Bermuda Monetary Authority view. BMA regulates the Bermuda-domiciled excess carriers; BMA-approved wordings have specific features baked into the supervisory framework. The Bermuda Form is regulated capital, regulated reserving, and regulated reporting; the BMA's Schedule IV-style capital framework treats Bermuda Form business as Class 4 high-impact business. The cedent and the carrier both operate within BMA's regulatory architecture even when the policyholder is US-domiciled and the dispute resolves in London.

The PFAS Mass-Tort Scenario

Insured: a chemical manufacturer (call it MidCentral Polymers, a US-domiciled multi-billion-dollar specialty chemicals company) with PFAS (per- and polyfluoroalkyl substances) exposure spanning 1995-2018 across three manufacturing facilities. Multiple thousands of claims filed against the insured 2020-2026 alleging environmental contamination (groundwater contamination at and around the manufacturing facilities), personal injury (residents and workers alleging health effects), property damage (residential and commercial property devaluation). The insured has Bermuda Form 006 $25M xs $25M layer effective policy periods 2018-2026 (renewed annually with the same carrier - call it Bermuda Specialty Casualty Ltd., a hypothetical Class 4 excess casualty carrier). The insured also has lower-layer insurance plus a self-insured retention covering the first $25M per occurrence; above the Bermuda Form layer sits a $200M excess tower across multiple Bermuda and London carriers.

Aggregate exposure: $4-12 billion projected across all claimants - a range driven by uncertainty in plaintiff counts, average settlement values, and litigation trajectory. The Bermuda Form carrier's exposure depends entirely on the five coverage questions; the answers turn the carrier's net exposure across the layer from zero (no occurrence within the policy period) to the full $25M layer limit per applicable occurrence per policy period (potentially aggregated to $200M+ across all renewals if multiple-occurrence theory and per-policy-year aggregation both apply).

The five coverage questions. (1) What constitutes "occurrence" - single occurrence (continuous exposure during the manufacturing period) or multiple occurrences (each claim or each manufacturing year)? (2) When was the occurrence "reported" to the carrier - at first claim 2020, at insured's first notification, at later development? (3) Does the "expected or intended" exclusion apply - was PFAS contamination expected or intended by the insured based on its internal knowledge timeline? (4) How does the batch and aggregation language apply - does the Bermuda Form aggregate PFAS claims into a single batch (per-product, per-condition) or treat them as separate occurrences? (5) What arbitration posture should the Bermuda carrier take - early settlement, mediated resolution, full arbitration?

The Occurrence Question

Bermuda Form 006 defines "occurrence" with specific language addressing continuous-exposure events. The language has been refined through case law and tribunal decisions over four decades. Two competing interpretations frame the PFAS analysis.

Continuous-exposure (single-occurrence) interpretation. The manufacturing of PFAS over 1995-2018 is a single continuous occurrence; aggregate damages across all claimants flow through one occurrence; one self-insured retention deductible applies (the insured eats the first $25M only once); one aggregate limit applies. This is reinsurer-favorable in limit-stacking analysis - the carrier's total exposure is capped at $25M for the entire long-tail claim cohort. The interpretation is supported by NY case law where continuous-exposure events have been treated as single occurrences when the underlying cause is continuous (manufacturing processes, environmental discharges).

Multiple-occurrence interpretation. Each year of manufacturing is a separate occurrence; each year requires a separate deductible; each year has separate aggregate. This is insured-favorable in deductible-stacking (one $25M retention per year over 23 years would be punitive; the insured argues for a single retention or a few retentions) but potentially reinsurer-favorable in limit-stacking (each year's $25M limit available for the year's claims; the insured-favorable theory expands aggregate limits to $200M+ across the renewal sequence). The interpretation is supported by NY case law where discrete events have been treated as separate occurrences.

2026 AI-driven aggregation analysis. Bermuda-domiciled carriers (Munich Re Bermuda, Tokio Marine HCC, Markel Bermuda, AXA XL Bermuda) deploy AI tools to analyze aggregation across long-tail claims. The tools include: NLP analysis of claim narratives identifying common-cause patterns; statistical clustering identifying claim cohorts by exposure year, geography, or product line; legal-precedent analysis on similar aggregation outcomes in NY-substantive-law jurisdictions. AI surfaces aggregation theories; coverage counsel (typically London-based with NY-bar expertise) determines the final theory based on the specific Bermuda Form 006 language and the most analogous case law. AI does not decide; AI accelerates the analysis that the credentialed coverage counsel signs.

The Reporting Trigger

"Occurrence-reported" coverage means coverage attaches when the occurrence is reported to the carrier, not when it occurred. This is critical because the reporting trigger defines which policy period responds. For the PFAS scenario: the contamination may span 1995-2018 (when manufacturing happened); the reporting trigger looks at when the occurrence was reported to the insured (by claimants or by regulators) and when reported by the insured to the Bermuda carrier.

Bermuda Form 006 reporting language typically requires the insured to notify the Bermuda carrier upon becoming aware of facts indicating an occurrence. The notification standard is fact-sensitive: did the insured become aware in 2010 when internal toxicology research raised concerns? In 2015 when regulatory enforcement actions began? In 2020 when the first major class-action complaint was filed? Notification before 2020 may trigger an earlier policy period (and possibly an earlier policy where the carrier was a different entity or the limit was lower); notification at 2020 triggers the 2020 policy period.

The coverage position turns on the factual development of the insured's knowledge timeline. The insured produces documents on internal research; the carrier produces documents on prior notifications and reservation-of-rights letters; counsel for both sides argue the "first awareness" date that NY substantive law and Bermuda Form 006 language support. The arbitration tribunal will make findings of fact on the timeline.

The 2026 AI overlay. AI tools assist the carrier's coverage counsel in document review at scale - millions of pages of insured-produced documents, regulatory filings, internal toxicology research, communications with environmental consultants. The tools surface key documents (internal memos showing knowledge of PFAS hazards, regulatory inquiries the insured received, decisions the insured made about disclosure). AI accelerates the discovery review; coverage counsel makes the case-theory call; the arbitration tribunal decides the factual question.

Expected or Intended Exclusion

Bermuda Form 006 typically excludes liability for occurrences expected or intended by the insured. The exclusion applies where the insured knew or should have known that the conduct would result in liability. For PFAS: did the insured expect or intend the environmental contamination and the resulting claims? The legal standard under NY substantive law is fact-sensitive and turns on insured-specific evidence.

Factors the tribunal will weigh. The insured's internal research on PFAS hazards (early toxicology studies, internal memos discussing health concerns, decisions about disclosure); the insured's response to regulatory inquiries (EPA, state environmental agencies, OSHA); the insured's safety practices and disclosures (community right-to-know filings, SDSs, worker protection); the broader industry's knowledge timeline (when did 3M's settlement disclosures change the baseline; when did the C8 Health Project results become public; when did EPA's Health Advisory on PFOA and PFOS publish).

The insured's defense. The PFAS regulatory and scientific landscape was uncertain through 2010-2015; the insured's conduct was consistent with industry practice; expected-or-intended does not apply to negligence - the insured may have been negligent in not disclosing or in not investigating, but it did not intend the resulting harm. The insured-side argument tracks NY case law that distinguishes intentional from negligent conduct under "expected or intended" language.

The Bermuda carrier's potential position. The insured had internal knowledge of PFAS hazards prior to widely-disclosed regulatory awareness; expected-or-intended applies because the insured continued manufacturing while knowing of the hazards and the eventual liability exposure. The carrier-side argument leans on internal memos, the insured's risk-management committee minutes, and the insured's reserves disclosures in its SEC filings.

Coverage position turns on factual development and document discovery. The London arbitration tribunal makes findings of fact based on the documentary and testimonial record. NY substantive law on "expected or intended" provides the legal framework.

Aggregation and Batch Clauses

Bermuda Form 006 includes batch and aggregation clauses with specific architectures refined over decades. Batch clause: claims arising from the same product, process, or condition aggregate into a single batch - single deductible plus single aggregate limit applies to the batch. Aggregation clause: defines what constitutes the "same product, process, or condition" for batching purposes.

Per-product aggregation. All PFAS claims constitute a single batch because they arise from the same product line. Under this interpretation, the carrier's exposure is capped at the single batch's deductible plus aggregate limit - favorable to the carrier in limit-stacking.

Per-condition aggregation. All PFAS contamination at all facilities constitutes a single condition (the carrier's discharge of PFAS-bearing materials). Under this interpretation, claims aggregate similarly to per-product. Also reinsurer-favorable.

Per-claim aggregation (insured-favorable theory). Each claim is a separate occurrence with its own deductible and its own per-occurrence limit. This produces multiple deductibles (potentially punitive to the insured given the per-occurrence retention) but separate limit availability (insured-favorable if the per-occurrence limit is shared across all claims of a given type).

Per-year aggregation. Each policy year is a separate batch (the multiple-occurrence interpretation). 23 years of manufacturing produces 23 batches, each with its own deductible (punitive to the insured) and its own aggregate (cumulatively expansive across the renewal sequence - potentially $200M+ in aggregate limits if the insured prevails on both annual aggregation and limit-stacking).

Coverage counsel for both sides evaluate the specific Bermuda Form 006 language, the NY case law on similar aggregation questions, and the prior tribunal awards in long-tail mass-tort disputes. The aggregation theory chosen by the tribunal can swing the carrier's exposure from $25M to $200M+.

Arbitration Posture - London Arbitration, NY Law

London arbitration under New York substantive law is the contractual dispute-resolution mechanism. The dispute proceeds: the insured demands defense and indemnity from the Bermuda carrier; the carrier asserts coverage defenses (occurrence theory, reporting-trigger timing, expected-or-intended exclusion, aggregation theory); the parties enter London arbitration under the Bermuda Form's arbitration clause.

Tribunal composition. Typically three arbitrators - one selected by each party, one chair selected by the two party-appointed arbitrators or by an appointing authority. The arbitrators are senior commercial lawyers or retired judges with insurance expertise; many have experience in prior Bermuda Form disputes. The chair often comes from the LCIA (London Court of International Arbitration) panel or the LMAA (London Maritime Arbitrators Association).

Procedure. Pleadings, document production, witness statements, expert evidence, oral hearings in London (typically 5-15 hearing days for a major Bermuda Form dispute), written closing submissions, tribunal-issued award. The full process takes 18-36 months from demand to award. Award is binding and enforceable internationally via the New York Convention.

Substantive law. New York law governs interpretation. Tribunals apply NY case law on occurrence theory, reporting trigger, expected-or-intended, aggregation. The tribunal has discretion to weigh case law from analogous NY decisions even where no precedent perfectly matches.

The Bermuda carrier's posture. The coverage position memo is drafted with London arbitration plus NY law in contemplation from the outset. The position must withstand cross-examination at hearing; must be supported by NY case law and expert testimony; must address the documentary record including discovery production. Outside counsel for the Bermuda carrier is typically London-based commercial litigators with NY-bar expertise - firms with formal Bermuda Form practice groups (a handful of London Magic Circle firms plus US-firm London offices).

Munich Re Bermuda, Tokio Marine HCC, Markel Bermuda, AXA XL Bermuda - 2026 Market Posture

Munich Re Bermuda. Largest book among the four; deploys AI aggregation tools at portfolio level for mass-tort claim analysis; positioned cooperatively on aggregation theory where the Bermuda Form language and NY case law clearly support it (continuous-exposure theory frequently accepted); aggressive on expected-or-intended defenses where internal-knowledge documents support the carrier's position. Coverage counsel sourced from Magic Circle firms plus US-firm London offices.

Tokio Marine HCC. Mid-tier Bermuda book; uses AI tools for claim-narrative analysis and document review; pragmatic on aggregation; willing to settle when business-rational and when the settlement avoids precedent-setting tribunal awards; defenses calibrated to merits. Coverage counsel from London firms with insurance specialty.

Markel Bermuda. Specialty Bermuda book including long-tail casualty; balanced approach to coverage disputes - aggressive only on extreme defenses where the documentary record strongly supports the carrier; cooperative on settlement of disputes where the cost of arbitration approaches the disputed amount. Coverage counsel from US-firm London offices with strong NY case-law expertise.

AXA XL Bermuda. Large book; AI investment significant in 2024-2026 including aggregation-analysis tooling; sophisticated aggregation analysis from internal coverage team plus external counsel; aggressive on coverage defenses where contractually supported by Bermuda Form 006 language; collaborative with cedents on resolution where merits warrant. AXA XL's Bermuda book includes some of the largest mass-tort exposures in the market.

The cedent's analysis of carrier posture. Informs negotiating strategy in coverage discussions before formal arbitration. Carriers more flexible on settlement reduce the cedent's litigation cost and risk; carriers more likely to arbitrate produce binding decisions that affect the broader market. The cedent's coverage counsel maintains intelligence on each Bermuda carrier's recent posture from the broker market, prior arbitration outcomes, and external counsel relationships.

The Coverage Position Memo

The Bermuda carrier's coverage position memo synthesizes the analysis into a decision document. Sections: (1) facts (the insured, the claims, the policy periods, the alleged contamination, the regulatory and litigation timeline); (2) coverage analysis under each of the five questions (occurrence, reporting, expected-or-intended, aggregation, arbitration posture); (3) NY case-law citations supporting the carrier's position on each question; (4) anticipated insured counter-positions and how the carrier responds; (5) recommended position (deny coverage on specified grounds; accept partial coverage; reserve rights pending fact development; settle within parameters); (6) economic exposure analysis (low / mid / high scenarios); (7) recommended next steps (reservation-of-rights letter with specific defenses identified; coordination with reinsurance under the carrier's own retrocession program; engagement of London counsel for prospective arbitration).

AI-assisted drafting compresses 80-160 hours of manual coverage analysis to 24-48 hours. The AI structures the memo, surfaces NY case law, runs comparable-fact-pattern searches against prior tribunal decisions where publicly reported, and drafts the section-by-section analysis. Coverage counsel customizes the legal analysis, validates every citation against Westlaw or Lexis, makes the case-theory call, and signs. The credentialed reviewer in this workflow is a senior coverage lawyer with Bermuda Form expertise; the AI is the drafting assistant.

Key Takeaways

• Bermuda Form 004 (1986 base) and 006 (newer, refined through 2024-2025) - high-excess casualty with occurrence-reported coverage, London arbitration, NY substantive law. Bermuda-domiciled carriers include Munich Re Bermuda, Tokio Marine HCC, Markel Bermuda, AXA XL Bermuda. Regulated by BMA as Class 4 high-impact business.
• PFAS mass-tort scenario: $25M xs $25M Bermuda Form 006 layer at MidCentral Polymers (hypothetical) with multi-thousand claims; aggregate $4-12 billion exposure across the underlying tort book.
• Five coverage questions drive Bermuda Form analysis. Occurrence (single continuous vs. multiple discrete); reporting trigger (which policy period responds based on insured's first-awareness timeline); expected-or-intended exclusion (insured's internal knowledge of PFAS hazards); batch and aggregation clauses (per-product / per-condition / per-claim / per-year); arbitration posture (settle / mediate / arbitrate).
• 2026 AI-driven aggregation analysis includes NLP claim-narrative pattern detection, statistical clustering, NY case-law precedent analysis. AI surfaces theories; coverage counsel (London-based with NY-bar expertise) decides; tribunal makes the binding finding.
• Reporting trigger turns on insured's knowledge timeline. 2010 internal toxicology research vs. 2015 regulatory inquiries vs. 2020 first major class action - different policy periods triggered with different carrier entities and different limits potentially applicable.
• Expected-or-intended exclusion is fact-sensitive under NY substantive law. Insured's defense: regulatory and scientific uncertainty plus industry practice plus negligence-not-intent. Carrier's potential position: internal-knowledge documents support expected-or-intended; the tribunal weighs the documentary record.
• Aggregation theory can swing exposure from $25M to $200M+. Per-product or per-condition (single batch) is reinsurer-favorable; per-claim is insured-favorable on limit-stacking but punitive on deductible-stacking; per-year multiplies both deductibles and limits across renewal sequence.
• London arbitration tribunal of three arbitrators (LCIA / LMAA panels typical); NY substantive law; binding award enforceable internationally via the 1958 New York Convention. Process 18-36 months from demand to award; coverage position memo drafted for London-plus-NY forum from outset.
• Four Bermuda carriers' 2026 postures differ. Munich Re Bermuda and AXA XL Bermuda largest books plus AI investment plus aggressive on expected-or-intended; Tokio Marine HCC pragmatic on settlement; Markel Bermuda balanced. Cedent's carrier-posture analysis informs pre-arbitration strategy and negotiation positioning.